search
Back to results

Advanced Dementia and End-of-life

Primary Purpose

Advanced Dementia

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
provision of relevant information
Sponsored by
Technical University of Munich
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Advanced Dementia focused on measuring Palliative Care, advanced dementia, life-prolonging treatment, patient will, advanced care planning

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Person with dementia + caregiver live in the Munich area
  • Person with dementia lives in a nursing home or at home
  • Person with dementia is in an advanced stage of the disease (moderate to severe dementia)
  • Informed consent of the caregiver and the person with powers of attorney
  • Caregiver is German-speaking and able to read

Sites / Locations

  • Center for Cognitive Disorders

Outcomes

Primary Outcome Measures

Patients' Perceived Involvement in Care Scale
Involvement is expected, when caregiver at study end achieve one point more in the sum score (sum score maximum is eight points)

Secondary Outcome Measures

family caregivers´satisfaction with care
the adapted version of End of life in dementia-Satisfaction with Care, (SWC-EOLD)

Full Information

First Posted
November 13, 2017
Last Updated
April 12, 2019
Sponsor
Technical University of Munich
Collaborators
Bavarian State Ministry of Health and Care, German Alzheimer Society
search

1. Study Identification

Unique Protocol Identification Number
NCT03548142
Brief Title
Advanced Dementia and End-of-life
Official Title
Palliative and Hospice Care in Advanced Dementia: Experiences of Care Givers and Benefit of a Brochure Serving as a Decision-making Aid
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
July 11, 2017 (Actual)
Primary Completion Date
September 1, 2018 (Actual)
Study Completion Date
September 1, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Technical University of Munich
Collaborators
Bavarian State Ministry of Health and Care, German Alzheimer Society

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Palliative and hospice care in advanced dementia: experiences of care givers and benefit of a brochure serving as a decision-making aid Aims: Designing a brochure serving as an information tool and decision-making aid used to answer questions concerning palliative and hospice care for care-givers of persons with advanced dementia. The brochure shall demonstrate the possibilities and offerings of palliative and hospice care and shall serve to inform about the advanced stages of dementia, the legal basic principles in decision making and ethical problems, treatment options and (palliative) treatment goals. Survey of the palliative, palliative medical and hospice care of persons with advanced dementia in ambulatory settings, as well as in residential geriatric care and the experiences of the care-givers. By examining persons with dementia and inspecting the care documents and where applicable the medical files it is to be evaluated: which procedures of palliative and hospice care are practically implemented in ambulatory care and in residential geriatric care, which symptoms the persons with dementia suffer from and how those symptoms are (or are not) treated, to what extend caregivers are informed about relevant aspects how caregivers assess care and which problems, needs and requests exist. Piloting phase for the brochure. To test the comprehensibility and the acceptance of the brochure a study is planned. The caregivers are asked for their opinion whether the brochure is helpful. It is recorded if the reading of the brochure gets the caregivers to engage actively in the participative decision making process.
Detailed Description
Two visits at home or in the residential geriatric care at intervals of eight to twelve weeks are scheduled. The following data is collected at enrollment: Informed consent of the caregiver and of the patient or rather the caregiver with powers of attorney Sociodemographic data (caregiver and person with dementia), e.g. age, sex, education, degree of relationship Interview of the caregiver using standardized Examination of the person with dementia, recording of the treatment and the care situation, cognitive status: Mini-Mental-Status-Test, severity of dementia: Clinical Dementia Rating Scale, performance in basic activities of daily living: Barthel-Index,communication competence, diagnosis, (palliative) medical and hospice care (including specialists in palliative care, specialists in hospice care, general practioners, domiciliary care services, Allgemeine Ambulante Palliativversorgung [AAPV], Spezielle Ambulante Palliativversorgung [SAPV], AAPV and SAPV both being a specific ambulatory palliative care of the statutory health insurance system in Germany, cognitive/neurological/physical symptoms, symptom Management including pharmacological and non-pharmacological treatment, interventions, existence and phrasing of advanced directives and durable power of attorney. After enrollment the brochure is handed and explained to the caregivers and they are encouraged to read it. It is pointed out that they are contacted after two to three months to answer questions concerning comprehensibility, acceptance, practical consequences and to give a personnel review. At study end after two to three months standardized interviews are conducted to gather information about comprehensibility and acceptance of the brochure, how it is reviewed by the caregivers and if the reading had direct consequences with regard to knowledge of the caregiver, communicating with nursing staff/physicians, decision making and implementing those decisions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Advanced Dementia
Keywords
Palliative Care, advanced dementia, life-prolonging treatment, patient will, advanced care planning

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
38 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
provision of relevant information
Intervention Description
caregivers are provided with brochure that informs about end-of-life issues for persons with advanced dementia
Primary Outcome Measure Information:
Title
Patients' Perceived Involvement in Care Scale
Description
Involvement is expected, when caregiver at study end achieve one point more in the sum score (sum score maximum is eight points)
Time Frame
two to three months
Secondary Outcome Measure Information:
Title
family caregivers´satisfaction with care
Description
the adapted version of End of life in dementia-Satisfaction with Care, (SWC-EOLD)
Time Frame
Assessment A (inclusion/baseline, before reading the brochure) and Assessment B (after reading the brochure, two to three months after Assessment A)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Person with dementia + caregiver live in the Munich area Person with dementia lives in a nursing home or at home Person with dementia is in an advanced stage of the disease (moderate to severe dementia) Informed consent of the caregiver and the person with powers of attorney Caregiver is German-speaking and able to read
Facility Information:
Facility Name
Center for Cognitive Disorders
City
Munich
State/Province
Bavaria
ZIP/Postal Code
81675
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
1202204
Citation
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.
Results Reference
background
PubMed Identifier
8232972
Citation
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993 Nov;43(11):2412-4. doi: 10.1212/wnl.43.11.2412-a. No abstract available.
Results Reference
background
PubMed Identifier
14258950
Citation
MAHONEY FI, BARTHEL DW. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J. 1965 Feb;14:61-5. No abstract available.
Results Reference
background
PubMed Identifier
2299426
Citation
Lerman CE, Brody DS, Caputo GC, Smith DG, Lazaro CG, Wolfson HG. Patients' Perceived Involvement in Care Scale: relationship to attitudes about illness and medical care. J Gen Intern Med. 1990 Jan-Feb;5(1):29-33. doi: 10.1007/BF02602306.
Results Reference
background
PubMed Identifier
15690832
Citation
Vohra JU, Brazil K, Hanna S, Abelson J. Family Perceptions of End-of-Life Care in long-term care facilities. J Palliat Care. 2004 Winter;20(4):297-302.
Results Reference
background
PubMed Identifier
17537084
Citation
Biola H, Sloane PD, Williams CS, Daaleman TP, Williams SW, Zimmerman S. Physician communication with family caregivers of long-term care residents at the end of life. J Am Geriatr Soc. 2007 Jun;55(6):846-56. doi: 10.1111/j.1532-5415.2007.01179.x.
Results Reference
background
PubMed Identifier
35802350
Citation
Ryan RE, Connolly M, Bradford NK, Henderson S, Herbert A, Schonfeld L, Young J, Bothroyd JI, Henderson A. Interventions for interpersonal communication about end of life care between health practitioners and affected people. Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
Results Reference
derived
PubMed Identifier
32164707
Citation
Riedl L, Bertok M, Hartmann J, Fischer J, Rossmeier C, Dinkel A, Ortner M, Diehl-Schmid J. Development and testing of an informative guide about palliative care for family caregivers of people with advanced dementia. BMC Palliat Care. 2020 Mar 12;19(1):30. doi: 10.1186/s12904-020-0533-3.
Results Reference
derived
Links:
URL
https://www.gkv-spitzenverband.de/media/dokumente/krankenversicherung_1/hospiz_palliativversorgung/versorgungsplanung/Vereinbarung_nach_132g_Abs_3_SGBV_ueber_Inhalte_und_Anforderungen_der_gesundheitlichen_Versorgungsplanung.pdf
Description
legal basis for AAPV and SAPV
URL
https://decisionaid.ohri.ca/docs/develop/Tools/PrepDM.pdf
Description
Preparation for decision making scale

Learn more about this trial

Advanced Dementia and End-of-life

We'll reach out to this number within 24 hrs